Biotech Values

[caravon]

Due,
Thanks for sharing your thoughts.

IMHO, the last scare regarding to a V-Pak label change or even potential FDA stopping V-Pak marketing led to a huge ENTA's share price dive. Many shorts jumped into this game too late. When ENTA went from $16 to $30 good many shots were trapped.

Presently, ~30% of all ENTA shares are short and these shorts are trying to get out driving the prices down.

Fundamentally, ENTA financial positions will improved due to Japanese V-Pak marketing.